Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
Published Online: 2021-12-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alexandra Leary•Alla Lisyanskaya•Amit Oza•Ana Oaknin•Anne Floquet•Antonio González-Martín•Byoung-Gie Kim•Carol Aghajanian•Charlie Gourley•Eileen Holmes•Elizabeth S Lowe•Gabe S Sonke•Giovanni Scambia•Kathleen N Moore•Michael Friedlander•Nicoletta Colombo•Paul DiSilvestro•Susana Banerjee•William H Bradley
